Unknown

Dataset Information

Capturing Data in Rare Disease Registries to Support Regulatory Decision Making: A Survey Study Among Industry and Other Stakeholders.


ABSTRACT:

Introduction

In rare diseases, registry-based studies can be used to provide natural history data pre-approval and complement drug efficacy and/or safety knowledge post-approval.

Objective

The objective of this study was to investigate the opinion of stakeholders about key aspects of rare disease registries that are used to support regulatory decision making and to compare the responses of employees from industry to other stakeholders.

Methods

A web-based survey was used to gauge the importance of (1) common data elements (including safety outcomes), (2) data quality and (3) governance aspects that are generic across different rare diseases. The survey included 47 questions. The data were collected in the period April-October 2019.

Results

Seventy-three respond

SUBMITTER: Jonker CJ 

PROVIDER: S-EPMC8279983 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature